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Calcium signaling
shRNA knockdownTSH is an important stimulus to maintain thyroid epithelial differentiation. Impairment of TSH signal
transduction can cause thyroid pathologies such as hot nodules, goiter and hyperthyroidism. In a gene
expression study in Fischer rat thyroid cells (FRTL-5) using cDNA microarrays we found a TSH-dependent
regulation of several calcium binding proteins, S100A4, S100A6 and annexin A6. Expression of these genes in
FRTL-5 and regulation by TSH was conﬁrmed with LightCycler qPCR and Western blotting. The differential
expression of S100A4 was conﬁrmed for cultured primary human thyrocytes. Calcium-imaging experiments
showed that prestimulation with TSH attenuates ATP-elicited P2Y-mediated calcium signaling. Experiments
with thapsigargin, TSH and calcium-free perfusion excluded an involvement of other purinergic receptors or
an involvement of SERCA regulation. Instead, we ﬁnd a correlation between S100A4 expression and the
effects of TSH on calcium signaling. Overexpression of S100A4 in FRTL-5 and shRNA-mediated knockdown of
S100A4 in follicular thyroid cancer cells (FTC133) conﬁrm the ability of S100A4 to attenuate calcium signals.
Under repeated stimulations with ATP the calcium retention of these cells is also modulated by S100A4,
suggesting a role of S100A4 as calcium buffering protein. As a biological consequence of S100A4
overexpression we detected reduced ATP-stimulated cFos induction. Taken together, the results suggest
that S100A4 and other calcium binding proteins are part of a signaling network connecting TSH signaling to
calcium-mediated events which play a role in thyroid physiology like H2O2 production or even thyroid
cancer.yrotropin; hTSHR, human TSH
P, Ca2+ binding proteins
ipzig, Germany. Tel.: +49 341
hn).
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Important aspects of thyrocyte differentiation including iodide
uptake and thyroid hormone synthesis depend on TSH [1]. Hence, the
human TSH receptor (hTSHR) is an predominant target in thyroid
diseases. Upon stimulation, the receptor mainly acts through Gαs
signaling which leads to an intracellular cAMP increase, cAMP
response element activation and subsequent gene transcription.
Although many of the observed physiological effects of TSH on
thyrocytes are mediated by the cAMP pathway, signaling through
Gαq/11 and Gβγ subunits has recently attracted additional attention
[2,3]. Gαq/11 and Gβγ pathways might involve Ca2+as a second
messenger in downstreamevents. In thyrocytes, intracellular Ca2+actsas a signal co-regulating proliferation when elicited by sphingosine-1
phosphate [4], purines [5] and Ghrelin [6] or prolongs the survival of
thyrocytes when mitochondrial Ca2+suppresses apoptosis [7,8].
Moreover Ca2+ is known to regulate physiologic events like H2O2
production by directly regulating the dual oxidases [9]. We and others
have recently stressed the importance of oxidative stress very likely
caused by H2O2 for thyroid tumorigenesis [10,11] and its interaction
with iodine deﬁciency [12], an important environmental condition
that is associated with thyroid diseases [13].
In order to examine the components that regulate thyrocyte
differentiation we studied TSH-induced global mRNA expression in
FRTL-5 Fischer rat thyroid cells which express human wild type (wt)
or constitutively activated mutant (CAM) hTSHR found in benign
autonomous tumors. Analysis revealed only minor expression
differences between the clones. However, a common feature was
the expression of several calcium binding proteins (CaBP) including
S100 proteins, calmodulins and members of the annexin family that
could interact with Ca2+ signals. Some of these proteins, e.g. S100a4,
S100a6 and annexin A6 showed a TSH-dependent regulation in all
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human thyrocytes and conﬁrmed a TSH-dependent regulation of S100
proteins which have so far been reported as early marker of thyroid
cancer. The S100 proteins are comprised of a hydrophobic hinge
region that connects two EF-hands. These EF-hands bind Ca2+ at
physiologic concentrations. Therefore, a higher level of S100 expres-
sion might buffer or retain intracellular Ca2+ and terminate or at-
tenuate Ca2+ signals. To test this hypothesis, we analyzed Ca2+ ﬂuxes
in FRTL-5 after stimulating the ubiquitous purinergic P2Y receptors
[14,15] with ATP. These G protein-coupled receptors signal through
the Gαq–PLC-pathway and lead to an intracellular Ca2+ rise via
inositol-1,4,5-trisphosphate receptor activation. This Ca2+ signal is
terminated by the action of sarco/endoplasmatic reticulum Ca2+
ATPases (SERCA) [16]. TSH treatment led to signiﬁcant changes in
FRTL-5 Ca2+ signalingwithout changes of SERCA. Correlation between
S100 protein levels and the modulation of Ca2+ signals suggests a
causal link that we explored by studying Ca2+ ﬂuxes in FRTL-5 after
overexpression of S100A4. To examine the effect of shRNA-mediated
knockdown of S100A4 on Ca2+ ﬂuxes we studied a follicular thyroid
cancer cell line (FTC133) with high endogenous expression of
S100A4. Finally, we determine the inﬂuence of S100A4 overexpression
on Ca2+-dependent induction of cFos expression by ATP.
We demonstrate that S100A4 has signiﬁcant impact on Ca2+
signaling and its downstream events. Because Ca2+ is a central and
ubiquitous link in many signaling pathways our study might deﬁne a
mode for S100A4 action in processes like metastasis, proliferation and
cell–cell-signaling in various cancers.
2. Materials and methods
2.1. Cell culture and transfection
The FRTL-5 cells used in our experiments stably express human
wild type [17] or mutant (A623I [18], L629F [19]. Del613–21 [20]) (CAM)
hTSHR. Their generation and culture was described in detail before
[21]. They were maintained in DMEM:HAMS-F12:MCDB-104 in a
2:1:1 ratio at 37 °C and 5% CO2. The medium was supplemented with
5% neonatal calf serum and 1 mU bovine TSH, 10 μg/mL insulin,
0.4 μg/mL hydrocortisone, 5 μg/mL transferrine and 45 μg/mL ascor-
bic acid (all from Sigma-Aldrich, St. Louis, MO, USA), referred to as 5H
medium. Cells were grown and passaged in 5Hmedium and used until
passage 15. For experiments without transfection cells were plated at
2.6⁎10e4 cells per cm². Three days before TSH treatment 5H medium
was replaced with TSH-free 5Hmedium and 24 h before collecting the
cells 1 mU TSH was added. For transfection, FRTL-5 cells were plated
at 1.3⁎10e3 cells per cm² and grown for 24 h. 5H medium was
replaced with serum-free medium and transfection was performed
with Lipofectamine and PLUS reagent (both Invitrogen, Carlsbad, CA,
USA) using 0.2 μg DNA per well. After 12 h, the medium was replaced
with fresh 5H medium and the cells were incubated for another 48 h
before conducting experiments.
FTC133 cells were maintained in DMEM supplemented with 10%
fetal calf serum (FCS). For transfection, cells were plated into a 12-
well plate containing glass coverslips at 2.6⁎10e4 cells per cm2 and
grown for 24 h. Transfection was performed using GeneJammer
(Stratagene, La Jolla, CA, USA) and 2.5 μg DNA per well.
HEK293 GripTite cells (Invitrogen) were maintained in DMEM
high glucose medium supplemented with 10% FCS, 0.1 mM non-
essential amino acids and 600 μg/mL G418 (both Invitrogen).
Culturing and plating for experiments was identical to FTC133.
2.2. Preparation and culture of human thyrocytes
Biopsies of normal surrounding tissues were taken during surgery
for nodular thyroid disease. The present study was approved by theEthics Committee of the Medical Faculty at the University of Leipzig
and informed consent was obtained from all patients before surgery.
The processing of tissue specimens and the preparation of follicles
was described before in detail [22]. Follicles were seeded into culture
dishes and maintained in RPMI-1640 with 1% fetal calf serum. After
24 h cells were washed with PBS to remove remaining erythrocytes
and medium was replaced with serum-free RPMI-1640. Stimulation
was performed 24 h before experiments with 1 mU TSH.
2.3. RNA isolation
Total RNA was isolated from untreated or TSH-stimulated cells
using TRIzol reagent (Invitrogen) according to the manufacturer's
instructions. Afterwards, RNA was puriﬁed with RNeasy kits (Qiagen
Hilden, Germany) following the manufacturer's instructions. RNA
content and quality was assessed by O.D. reading and by determining
the A260/280 ratio. RNA integrity was evaluated on ethidium bromide-
stained agarose gels. For microarray analysis, RNA integrity and
concentrationwas examined on an Agilent 2100 Bioanalyzer using the
RNA 6.000 LabChip Kit (Agilent Technologies, Palo Alto, CA, USA)
according to the manufacturer's instructions.
2.4. DNA microarray
Microarray analysis was conducted at the microarray core facility
of the Interdisciplinary Center for Clinical Research Leipzig (Faculty of
Medicine, University of Leipzig, Germany). 5 μg of total RNA were
used to prepare double-stranded cDNA (Superscript II, Life Technol-
ogies, Gaithersburg, MD USA) primed with oligo-dT containing an T7
RNA polymerase promoter site (Genset SA, Paris, France). cDNA was
puriﬁed by phenol–chloroform extraction before in vitro transcription
using the IVT labeling kit (Affymetrix, Santa Clara, CA, USA) to
synthesize cRNA. After the in vitro transcription, unincorporated
nucleotides were removed using the RNeasy kit (QIAGEN). The cRNA
was fragmented and hybridized to Affymetrix GeneChip RG230 2.0
arrays. The washing and staining of the array was performed
according to the manufacturer's instructions. The array was scanned
with a third generation Affymetrix GeneChip Scanner 3000 with the
7G upgrade.
2.5. Quantitative Real-time-PCR
cDNA was synthesized from 1 μg of total RNA using 200 U MMLV
reverse transcriptase (Invitrogen, Carlsbad, CA, USA), oligo-dT for
priming and 15 U peqGOLD RNAse inhibitor (Peqlab, Erlangen,
Germany). 1 μL of the cDNA reaction was quantiﬁed on a LightCycler
real-time PCR thermocycler using SYBR-Green master mix (Roche
Diagnostics GmbH, Mannheim, Germany) for detection. Total copy
number was calculated by using a standard curve obtained by
measuring a serial dilution (10e−2 to 10e−8) of the PCR product
cloned into pGEM-T easy (Promega, Madison, WI, USA). All samples
were normalized to their Rps6 (rat ribosomal protein S6, NM_017160)
or RPL27 (human ribosomal protein L27, NM_000988.3) expression.
For primer sequences please see online supplement.
2.6. Cloning of S100 proteins
We used cDNA obtained from human thyroid biopsies as template
and performed a PCR using the primers given below. The resulting
product contains the full coding sequence and the 5′ upstream Kozak
sequence. It was cloned into pIRES-dsRedExpress (Clontech-Takara Bio
Europe, Saint-Germain-en-Laye, France) using XhoI and BamHI restric-
tion sites. This vector contains an internal ribosome entry site (IRES) that
allows the expression of the S100 protein and the red ﬂuores-
cent dsRedExpress protein in stochiometrically equivalent manner.
DsRedExpress ﬂuorescence reports transfection and transcription
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imaging experiments. For primer sequences please see online
supplement.
2.7. Small hairpin RNA knockdown of S100A4
We ligated pre-digested pGSH1-GFP vector (Genlantis, San Diego,
CA, USA) and two annealed complementary 63 bp- S100A4-shRNA
oligos (see online supplement) according to the manufacturer's
instructions. pGSH1-GFP allows the expression of small hairpin RNAs
using a human RNA polymerase II promoter simultaneously with GFP.
FTC133 cells were transfected with S100A4-shRNA or luciferase-
shRNA containing control vector (Genlantis) as described. Knockdown
was assessed using Western blotting for S100A4 protein. Five days
after transfection cells were used for calcium-imaging measurements.
2.8. Calcium imaging
For ﬂuorescence measurements cells were loaded with 1 μM Fura-
2 AM (Molecular Probes, Invitrogen, Carlsbad, CA, USA) for 30 min at
35 °C. Measurements were performed at room temperature under
constant perfusion with 1 mL/min Ca2+- and Mg2+-free HBSS
(Hank's Balanced Salt Solution, Sigma-Aldrich Chemie GmbH,Munich,
Germany). For some experiments 2 mM Ca2+ was added to the HBSS.
The cells were stimulated by computer-controlled addition of the
stimulus to the perfusion. Fluorescence was excited at 340 and
380 nm and was recorded at 525 nm. Images were taken every 6 s
with a TillVision imaging system (Till-Photonics; Munich, Germany;
consisting of iMic, Polychrome V, Imago Camera and Till Vision
Software). The recorded images were further processed using the
ImageJ forMicroscopy package [23] (MacMaster Biophotonics Facility,
Hamilton, ON, Canada).
2.9. Western blotting
Cell lysates were prepared using RIPA buffer containing complete
protease inhibitor tablets (Roche Diagnostics GmbH, Mannheim,
Germany) as described elsewhere [24]. Protein levels were deter-
mined using the BCA assay (Thermo Fisher Scientiﬁc Inc., Rockford, IL,
USA). Equal amounts of protein were subjected to 16% Laemmli SDS-
PAGE [25] and semidry electroblotting onto a 0.2 μm nitrocellulose
membrane (Schleicher & Schuell GmbH, Einbeck, Germany) [26].
Membranes were blocked with 3% BSA and detection of proteins was
performed using anti S100A4mousemAb (1:1000) or anti annexin A6
rabbit polyclonal Ab (1:400; both Abcam plc, Cambridge, UK).
Chemiluminescence detection from HRP-conjugated secondary anti-
bodies (1:3000; Cell Signaling Technologies, Danvers, MA, USA) was
performed with a CCD camera. The density of protein bands was
acquired with ImageJ by generating lane intensity proﬁle plots and
measuring the areas of the peaks above baseline.
2.10. Data analysis
Affymetrix GeneChip data representing approximately 31,000 rat
transcripts with complete Genome coverage were extracted from
ﬂuorescence intensities and were scaled in order to normalize data for
inter-array comparison using MAS 5.0 software according to instruc-
tions of the manufacturer (Affymetrix, Santa Clara, CA, USA). Differen-
tially expressed genes were detected using Signiﬁcance Analysis of
Microarrays [27].
Data obtained from other experiments were analyzed using Prism
4.0 (Graphpad Software Inc. San Diego, CA, USA). Data were tested for
Gaussian distribution using D'Agostino and Pearson omnibus normal-
ity test. Since calcium imaging data showedno normal distribution,we
used the nonparametric two-tailed Mann–Whitney ranksum test to
test for signiﬁcant differences. Signiﬁcances are indicated as (*)p<0.05, (**) p<0.01 and (***) p<0.001. For the analysis of correlation
between mRNA and protein expression levels showing Gaussian
distribution, we used Pearson's two-tailed correlation; otherwise
Spearman's correlation was used.
3. Results
3.1. TSH-regulated gene expression
We conducted a microarray analysis to detect differential gene
expression patterns in FRTL-5 cells expressing wt or CAM hTSHR after
stimulation with 1 mU bovine TSH for 24 h. Important functional
aspects of these FRTL-5 clones have been reported recently [28]. An
upregulation of thyroid-speciﬁc genes upon TSH-stimulation indi-
cates typical thyrocyte responses in all FRTL-5 clones (e.g. 1.9-fold for
Tpo and 4.6-fold for Slc5a5, average for all clones and experimental
replicates, data not shown). Since gene expression differences
between wt and CAM hTSHR clones are very subtle and complex we
will only report on general aspects of TSH stimulation common to all
FRTL-5 clones studied.
Statistical analysis of three independent experiments using the
statistical analysis formicroarrays algorithm revealed318 signiﬁcantly
regulated probe sets representing 257 annotated genes for the
comparison of TSH-treated vs. untreated cells. This list was subjected
to functional annotation clustering with DAVID 2008 (Database for
Annotation, Visualization and Integrated Discovery [29,30]) using all
genes on the GeneChip RG230 as background setting. The algorithm
was used with default settings for clustering and results were ﬁltered
for enrichments with a signiﬁcance greater than 0.01. Functional
annotation highlighted a groupwith the gene ontology term “calcium-
dependent phospholipid binding”, containing all annexin genes, as
overrepresented compared to all genes detectable with the RG230
GeneChip. We therefore focused further analysis on the differential
expression of Ca2+-binding proteins (CaBP). Fig. 1 illustrates the ex-
pression of members of the annexin, S100 and calmodulin families of
CaBPs in our FRTL-5 clones. The most highly expressed transcripts are
Anxa2, Anxa5 and Calm2 (mean expression of 4048, 3663 and 4123
MAS5.0 arbitrary units), whilemost S100 proteins like S100a1, S100a4
and Anxa7 show intermediate to weak expression (348, 198 and 352
MAS5.0 arbitrary units). For most transcripts changes after TSH
treatment are rather uniform in all clones except for S100a4 and
S100a6which show a higher increase in the A623I and del613–21 clones.
To more exactly assess the extent of transcript regulation, we used
lightcycler qPCR (Fig. 2A) for validation because of its wider dynamic
range [31]. Only Anxa6 (3.65 fold, p=0.0213), S100a4 (5.74 fold,
p=0.0225) and S100a6 (6.5 fold, p=0.0165) show signiﬁcant
upregulation when tested with a nonparametric two-tailed Mann–
Whitney U test. Anxa11 is downregulated nearly two-fold but fails to
reach statistical signiﬁcance (p=0.06).
In addition to the regulation of Ca2+-binding related genes at the
transcript level we also studied protein expression. First, Anxa6
protein expression in TSH-stimulated FRTL-5 clones was analyzed
(Fig. 2B). Densitometric analysis of three independent blots and
correlation of the mean β-actin normalized protein expression values
with the respective mRNA expression value for each clone revealed a
good correlation (two-tailed Spearman r=0.881; p=0.0072) be-
tween transcript and protein. A similar correlation was detected for
S100a4 (two-tailed Spearman r=0.833; p=0.0154, data not shown).
Besides FRTL-5 cells, primary human thyrocytes were used to
analyze the effect of TSH on the S100a4 transcript and protein level.
Primary human thyrocytes from 9 different patients were cultured as
described and stimulated for 48 hwith 1 mU TSH. The differentiation of
our primary cultures was assessed by analyzing TPO mRNA expression
along with the expression of S100A4 mRNA (Fig. 3A). All cultures
showed a moderate to high increase of TPO expression after TSH
treatment (geometric mean 9.9 fold, p=0.09, not shown) but no
Fig. 2. Veriﬁcation of microarray results using qPCR and Western blotting (A) cDNA
samples used for the microarrays were subjected to LightCycler qPCR. The mean fold-
change of mRNA expression after stimulation with 1 mU TSH for 24 h was calculated as
log2-fold using the mean of all cDNAs. Mann–Whitney U test was performed to
determine signiﬁcant gene regulations. *p<0.05. (B) Anxa6 mRNA expression values
from (A) were correlated with the relative expression of annexin A6 protein. Protein
expression of each sample was normalized to its beta-actin protein after densitometry
of three Western blots and averaged within the respective clone and stimulation
condition. Below one of the three blots is shown. Spearman r=0.881, p=0.0072.
Fig. 1. Differential expression of genes encoding for CaBPs. Affymetrix GeneChip RG230
expression analysis of FRTL-5 clones stimulated with 1 mU for 24 h was performed in
triplicate. The FRTL-5 cell clones constitutively expressedwt or CAM (del613–21, A623I,
L629F) hTSHR. For all genes of CaBPs (see HUGO gene symbols for identity) that
received “present” calls by the Affymetrix MAS5.0 software in at least 3 samples, log2-
fold changes after stimulation with TSH were calculated and colorized according to the
gradient legend, ranging from −2.5 to 2.5-fold. The average expression level of each
gene for all experiments is shown in the right column as MAS5.0 arbitrary expression
intensity units in order to differentiate between low, medium and high expression
levels.
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correlation of the sample's individual TPO and S100A4 expression
(Pearson r=0.6647, p=0.005). Anyhow, expression of S100A4 upon
TSH treatment is increased in primary cultures with a strong TPO/
differentiation response but decreased in cultures with a low TPO/
differentiation response. A strong correlation is found between S100A4
transcript and protein expression (Fig. 3B, Pearson r=0.9179,
p=0.0013). Transcript and protein data suggest that S100A4 regulation
is biphasic in regard to the differentiation potential of the primary
culture.3.2. Effects of TSH, ATP and thapsigargin on Ca2+ signaling
In order to evaluatewhether differential expression of CaBPs has an
impact on Ca2+ signaling in thyroid cells ratiometric calcium-imaging
measurements using Fura-2 AM was done. TSH did not trigger a Ca2+
response in FRTL-5 wt or CAM hTSHR after stimulation with 100 mU
TSH under perfusion with HBSS containing 2 mM Ca2+ (Fig. 4A). ATP
was used to elicit a Ca2+ response via ubiquitous P2 receptors. 100 μM
ATP induced a strong and transient biphasic intracellular Ca2+ release,
consisting of a fast initial rise which declines to a lower, but longer
lasting level above basal being represented as a right shoulder of the
peaks in Fig. 4B. Perfusion with Ca2+-free HBSS resulted in a
monophasic release, consisting of one fast Ca2+ release followed by
a fast decay to basal levels. When repeatedly stimulating FRTL-5 cells
with ATP, the second Ca2+ response provoked 15 min after the ﬁrst is
lower than the ﬁrst one. This effect is more pronounced when using
Ca2+-free perfusion solution. Treatment of FRTL-5with thapsigargin, a
SERCA inhibitor [32], abolished the ATP-induced Ca2+ release (Fig. 4C).3.3. Effects of TSH on ATP-induced Ca2+ signaling
To address the question whether TSH can modulate ATP-induced
Ca2+ signals, FRTL-5 were prestimulated for 2 or 24 h with TSH. After
2 h prestimulation with TSH up to 10 mU, no TSH effect on the ATP-
elicited Ca2+ responses was observed (data not shown). After 24 h
prestimulation using 1 mU TSH a signiﬁcant decrease of the ﬁrst Ca2+
response to ATP stimulation (Fig. 5A; p=0.0052) was observed. The
ratio of the height of the second to the ﬁrst Ca2+ peak increased
slightly but not signiﬁcantly. Correlation of the Ca2+ responses
obtained from wt and CAM hTSHR clones showing differences in
their CaBP expression level revealed a negative correlation between
the ﬁrst Ca2+ response and the TSH-dependent modulation of S100a4
and S100a6 mRNA expression levels (Fig. 5B).
3.4. Overexpression of S100A4
To examine the impact of CaBP expression on Ca2+ signaling in FRTL-
5 wt hTSHR, human S100A4 was overexpressed using a bicistronic
construct co-expressingdsRedExpress, a redﬂuorescentprotein that can
be excited at 560 nm and emits light at 590 nm. This approach allows
Fig. 3. Expression of S100A4 in primary human thyrocytes (A) Cultures of primary
human thyrocytes were stimulated with 1 mU TSH for 24 h and TPO and S100A4 mRNA
expression was analyzed using LightCycler qPCR. The samples were normalized to their
RPL27 expression. The boxplot shows the RPL27-normalized expression of S100A4 and
TPO. (B) For the same cultures the fold-change upon stimulation with TSH was
calculated for TPO and S100A4 and plotted against each other. Spearman r=0.8019,
p=0.0093. (C) S100A4 protein expression of TSH-stimulated primary human
thyrocytes was assessed withWestern blotting and correlated to the RPL27-normalized
mRNA expression. The primary human thyrocytes were treated as detailed in (A).
S100A4 protein expression was assessed using densitometry of Western blots and
calculated as S100A4 normalized to beta-actin. Spearman r=0.9297, p<0.0001.
Example blots are given below the graph.
Fig. 4. Calcium imaging by ratiometric ﬂuorescencemicroscopy of FRTL5wt hTSHR cells
loaded with 1 μM Fura-2 AM. The ﬂuorescence ratio of the emission at 525 nm with
excitation at 340 and 380 nm is shown nm in arbitrary units as mean+or±SEM.
(A) FRTL-5 wt hTSHR cells were perfused with HBSS+2 mM Ca2+ and stimulated with
10 mU TSH and 100 μM ATP for 1 min at the indicated times. The trace shows a
representative measurement of 12 cells. (B) FRTL-5 wt hTSHR cells were stimulated
with 100 μM ATP at 1 and 16 min. The dotted trace shows a measurement of 43 cells
perfused with HBSS+2 mM Ca2+. The solid trace shows a measurement of 35 cells
perfused with Ca2+-free HBSS. (C) FRTL-5 wt hTSHR cells were preincubated with
1 mM thapsigargin for 15 min and stimulated with 100 μM ATP under 2 mM Ca2+-
containing conditions. The trace shows the mean ﬂuorescence ratio of 25 cells.
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estimation of the extent of overexpression, since the bicistronic design of
the vector results in a ﬁxed ratio of expression levels between the
overexpressed gene and the reporter. After the functional veriﬁcation of
the construct in HEK293 cells that are optimized for high transfection
and expression efﬁciency, S100A4 was overexpressed in FRTL-5 wt
hTSHR and Ca2+ measurements were performed. DsRedExpress-positive, concurrently S100A4 overexpressing cells were compared to
untransfected dsRedExpress-negative cells on the same coverslip.
Although only a mild S100 overexpression was achieved compared to
HEK293 as estimated from ﬂuorescence intensities, the impact of
S100A4 overexpression on the Ca2+response characteristics is signiﬁ-
cant (Fig. 6). S100A4 protein reduced the height of the ﬁrst Ca2+
response peak by 20% from 0.852±0.015 (mean±SEM) to 0.685±
0.025 (p<0.0001) and increased the ratio of the second to the ﬁrst
responsepeakby45% from0.340±0.013 to0.498±0.0213(p<0.0001).
3.5. S100A4 knockdown in FTC133
FRTL-5 cells withwt hTSHR show a rather low expression of S100A4.
Very likely a knockdown in these cells would not be a suitable
experiment to demonstrate the consequences of S100A4 loss. Therefore,
human follicular thyroid cancer cells FTC133 were used for studying the
effects of S100A4 knockdown on Ca2+ signaling. FTC133 show a high
Fig. 5. Calcium imaging of FRTL-5 cells preincubated with TSH. (A) The effect of TSH on
the Ca2+ responses of FRTL-5 clones was assessed after 24 h preincubation with 1 mU
TSH (black bars) or untreated control cells (white bars). Stimulation of cells was done
with 100 μM ATP after 1 min (1st response) and 16 min (2nd response) of recording.
The response ratio is calculated as the ratio of the 2nd response peak to the 1st
response. Results are given asmean+SEM for 38 (control, white bars) or 35 (TSH, black
bars) independent measurements, irrespective whether wt or CAM hTSHR was
expressed. Each measurement consisted of at least 25 cells. *p=0.0162. (B) The
mean 1st Ca2+ response was obtained from at least three independent FRTL-5 cultures,
either wt or CAM hTSHR clones. The Ca2+ response obtained with TSH prestimulation
or control treatment was correlated with the mean S100a4 mRNA expression of the
respective culture, shown as log2-fold expression relative to the lowest expression
value. Pearson r=−0.6598, p=0.0375.
Fig. 6. Effect of S100A4 overexpression on Ca2+ ﬂuxes in FRTL-5 wt hTSHR. The upper
panel shows bright dsRedExpress ﬂuorescence at 560 nm (right picture, example
indicatedwith arrow) indicating S100A4 overexpressing cells compared to all Fura-2AM
loaded cells (upper left picture). Cells were accounted positive when f560 was 3-fold
above background ﬂuorescence. The lower panel shows Ca2+ measurements of FRTL5
wt hTSHR cells after stimulation with 100 μM ATP at 1 min (1st response) and 16 min
(2nd response) of recording. Measurements were performed for a total of 443 negative
(white bars) and 92 positive (black bars) cells and are expressed as mean+SEM
ﬂuorescence of the 1st response in arbitrary units or the ratio of 2nd to the 1st response.
***p<0.0001.
Fig. 7. Effect of S100A4 knockdown on Ca2+ ﬂuxes in FTC133 follicular thyroid cancer
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higher compared to primary thyrocytes. S100A4 protein expression is
also very high in FTC133, making these cells a good model for knock-
down studies. S100A4 protein was downregulated by transfecting an
anti-S100A4-shRNA expressing vector, achieving an average transfec-
tion efﬁciency of 50% in repeated experiments. This resulted in a 57%
decrease in S100A4 protein expression 5 days after shRNA transfection,
as determined by Western blotting (Fig. 7). When performing calcium
imaging with these cells, constitutive GFP expression from the same
vector was used as marker for transfected cells. Cells were accounted
positive when their GFP ﬂuorescence was higher than the mean GFP
ﬂuorescence of all observed cells in all experiments. Comparison of
FTC133 with a S100A4 knockdown to FTC133 control cells with a
luciferase shRNA induced changes in the Ca2+ ﬂux that are inverse to
S100A4 overexpression in FRTL-5 cells (Fig. 7). Knockdown of S100A4 in
FTC133 lead to a signiﬁcant 32% increase (p=0.051) of theprimary Ca2+
response compared to control cells expressing luciferase antisense
shRNA. The ratio of the responses was slightly decreased by 16%
(p=0.039).cells. FTC133 cells were transfected with an anti-luciferase-shRNA (white bars) or an
anti-S100A4-shRNA (black bars) producing vector to knock down S100A4 protein
expression. At day 5 after transfection, knockdown was 57% compared to control as
determined by Western blotting (lower part). Ca2+ responses were recorded as before
for control (n=36) or anti-S100A4-shRNA expressing cells (n=38). GFP expression
was measured at 525 nm with excitation at 485 nm as a marker for shRNA expression.
Only cells with GFP ﬂuorescence above the mean of all visually positive cells were
considered positive and used for the calculation of Ca2+ responses. Values are given as
mean+SEM. **p=0.0048; *p=0.0389.3.6. Effect of S100A4 expression on ATP-stimulated induction of cFos
mRNA expression
To demonstrate a molecular consequence of modulated calcium
signals, we analyzed the induction of cFos by 100 μM ATP in HEK293
GripTite cells which are optimized for a strong protein expression.Stimulation with 100 μM ATP for 30 min leads on average to an 11.5-
fold increase of cFos mRNA expression. Overexpression of S100A4 has
two effects. The unstimulated cFos levels increase insigniﬁcantly by
2.1-fold compared to control cells. Stimulation with 100 μM ATP
induced cFos mRNA (8.9-fold) to a lesser extent (76.9%) in S100A4
overexpressing cells compared to control cells (Fig. 8).
Fig. 8. Effect of S100A4 overexpression on ATP-stimulated induction of cFos mRNA. 48 h
after transfection with human S100A4-pIRES-dsRedExpress or pEGFP-N1 as control,
HEK293GriTite cellswere treatedwith 100 μMATP for 30 min. cFosmRNAexpressionwas
analyzedusing lightcyclerqPCRandnormalized toRPL27mRNAexpression. Stimulationof
control cells with 100 μM ATP leads to an 11.5-fold induction of cFos, which is reduced to
8.9 fold when overexpressing S100A4. Values are given as mean+SEM of 6 measure-
ments. *p=0.0321.
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Our results for the ﬁrst time focus attention to the attenuation of
Ca2+ signaling by TSH mediated differential expression of CaBPs. By
regulating the expression of such proteins, TSH possesses the
potential to ﬁne-tune Ca2+ signals in thyrocytes. Ca2+ regulates the
generation of H2O2 essential for thyroid hormone synthesis, the
activation of calmodulin-dependent kinases [33], the generation of
NO or the release of arachidonate [34] and prostaglandins [5]. Ca2+
signaling in thyrocytes has so far been considered in conjunction with
the cascade of direct TSH signaling mediated by Gαq and phospho-
lipase C activation [35]. However, in thyrocytes TSH predominantly
activates the canonical cAMP cascade [1,32] which leads through
activation of Gαs to accumulation of cAMP and consecutive activation
of PKA. This cascade essentially controls thyroid physiology and
growth, as illustrated by the effects of constitutively activating hTSHR
mutations that lead to cAMP accumulation and cause goiter and
hyperthyroidism. At the molecular level cAMP regulates the tran-
scription of thyroid peroxidase (TPO) and the Na+/I− symporter
which we used as markers for the TSH-dependent cAMP response.
In general it is noteworthy that the impact of the CAMs on our cell
model is not as strong as one would expect from in vitro data in
heterologous cell lines. This could be due to the basal activity that is
also found in wt hTSHR or the low amount of TSH used in this study
which might obscure differences found elsewhere [36].
We found the transcripts of several CaBPs to be present in rat
thyrocytes. At least three of them are signiﬁcantly increased by TSH:
Anxa6, S100a4 and S100a6. The latter two show a higher upregulation
in those clones that show increased basal inositolphosphate forma-
tion compared to wt hTSHR [20]. These differences suggest that
hTSHR Gαq signaling via IP3 or DAGmight be involved in S100a4 and
S100a6 regulation, at least in FRTL-5 cells.
Although we use expression of human hTSHR variants in non-
human thyroid cell line clones this approach might still be of limited
value for a comprehensive understanding of human thyroid physiol-
ogy [37] We therefore also studied S100A4 expression in primary
human thyrocytes. Primary thyrocytes often vary in their ability to
differentiate in culture, probably due to a number of technical (e.g.
asservation, purity and culture conditions) or unknown biological
factors. Despite a tight control of the technical factors we detect
changes of S100A4 expression upon TSH-stimulation that are more
complex than in FRTL-5. A direct comparison of mean S100A4 mRNA
expression levels from TSH-treated vs. untreated thyrocytes showed
no signiﬁcant differences between the groups. Nonetheless there is a
strong correlation between TPO and S100A4 expression revealing that
well-differentiated primary thyrocytes upregulate S100A4 as part oftheir physiological response. However, in thyrocytes with low
increases of the differentiation marker upon TSH treatment S100A4
expression is decreased. S100A4 protein expression is also under tight
control, as the observed changes in mRNA expression translate into
protein to a lower extent.
S100A4 has so far been associated with neoplasias [38] and
metastastatic potential of tumors [39]. The protein has been found in
anaplastic thyroid cancer [40] and in papillary thyroid cancer [41]. It
has been proposed as a marker to discriminate between follicular
adenoma and the follicular variant of papillary thyroid carcinoma [42]
and between PTC and FTCs [43]. Ito et al. [44] proposed the protein as
early marker for PTC detection. Here, we describe for the ﬁrst time
regulation of S100A4 in human thyrocytes by TSH. From the structural
properties of S100 proteins, i.e. the presence of two high-afﬁnity Ca2+-
bindingmotifs, we speculated that altered expressionmightmodulate
intracellular Ca2+signals.
S100 proteins are unlikely to modulate TSH signaling since TSH
itself did not elicit any Ca2+ response in our FRTL-5 clones, which
agrees with data by Singh et al. [45]. In human thyrocytes, a TSH-
dependent generation of inositol-1,4,5-trisphosphate has been
reported [46] and a Ca2+ release has been shown for unphysiologically
high TSH concentrations in some specimens [15]. Taken together, the
ability of TSH to trigger a Ca2+ release seems to depend very much on
the examined cell system.
However, S100 proteins could modulate Ca2+ signals from other
receptors expressed in thyrocytes like P2Y receptors. They stimulate
DNA synthesis through intracellular Ca2+ signals [47] and affect H2O2
production [34]. In cancer, P2Y receptors can either stimulate or
inhibit cell proliferation [48] and act synergistically with chemo- and
radiotherapy [49]. Furthermore, they mediate interactions between
cancer cells and endothelial cells [50].
ATP triggers the fast release of Ca2+ from intracellular stores in
FRTL-5 cells, which leads to a strong increase in intracellular Ca2+ and
is followed by a longer lasting capacitative Ca2+ entry, probably
through store-operated Ca2+ channels [51]. The ﬁrst phase of the Ca2+
response is sensitive to thapsigargin treatment. Preincubation of FRTL-
5 with thapsigargin inhibits SERCA leading to a leakage of Ca2+ from
the ER and inactivation of IP3-mediated signaling. A very small non-
signiﬁcant residual Ca2+ ﬂuctuation could be due to ATP-sensitive P2X
channels or due toDAG-activated Ca2+ channels. Nonetheless our data
demonstrate that these signaling pathways play no major role in ATP-
mediated Ca2+ signaling in thyrocytes. The second phase of the Ca2+
response was abolished by removing extracellular Ca2+, conﬁrming
that this part of the response originates from the extracellular space.
The decreasing Ca2+ responses after repeated stimulations with
ATP might be explained by homologous receptor desensitization, but
our experimental conditions during perfusion (i.e. short stimulus, long
delay) most likely exclude this possibility [52]. Instead, perfusion with
Ca2+-free HBSS prevents Ca2+ inﬂux through store-operated channels
and replenishment of Ca2+ stores. Repeated releases of intracellular
Ca2+ lead to gradual Ca2+ store depletion and a reduction of the Ca2+
pool that can be released from stores by subsequent stimulations, since
a signiﬁcant fraction of the mobilized Ca2+ is sequestered into the
extracellular space and thereby lost. Another fraction of the mobilized
Ca2+ is retained in the cell by Ca2+-buffering proteins and other
mechanism and is ﬁnally restored to the ER. Since we speculate that
the increased expression of CaBPs inﬂuences Ca2+ retention, we used
Ca2+-free conditions after the initial experiments. Otherwise, possible
effects of CaBPs may be overlaid by Ca2+-release activated Ca2+
currents and by a full replenishment of Ca2+ stores from the extra-
cellular space.
The observed decrease of FRTL-5 responsiveness to ATP upon
stimulation with TSH for 24 h could result from SERCA activity that is
modulated by a TSH-induced phosphorylation as described by
Ulianich et al. [53]. However, a short-time prestimulation with TSH
had no effect on Ca2+ signals, which argues against a mechanism
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more likely that the modulation of Ca2+ responses is due to variations
in CaBP expression such as annexin A6 and S100 proteins. Their
upregulation by TSH-stimulation strongly correlates with differences
in the ability to retain Ca2+, while expression of calmodulin or SERCA
was unaffected by TSH.
Overexpression of S100A4 led to a signiﬁcant decrease of the ﬁrst
Ca2+ response upon ATP stimulation similar to the decrease after TSH
stimulation. Vice versa, a knockdown of high endogenous S100A4 in
human follicular cancer cells FTC133 led to a strong increase of the
ﬁrst Ca2+ signal. A possible mode of S100A4 action might be a
modulation of Ca2+ ﬂuxes by binding and buffering Ca2+ ions
analogous to calbindin D28k [54]. Differential expression of annexin
A6 or S100A6 by TSH could contribute to the modulation of ATP-
induced Ca2+ signaling by the same proposed mechanism. It is also
possible that the changes in Ca2+ signaling are mediated further
downstream of S100 activity. Several interaction partners have been
functionally veriﬁed for S100A4, e.g. p53 which inﬂuences prolifer-
ation characteristics [55], or myosin which results in a modulation of
cell motility [56]. Annexin A2 is another conﬁrmed interaction partner
for S100A4 [57] and is, like S100A4 itself, a known CaBP expressed in
thyrocytes. Instead of a direct interference with Ca2+ ﬂuxes, S100A4
could inﬂuence signaling by binding and modulating other Ca2+-
signaling proteins. A competition of several CaBPs for free Ca2+ seems
also possible because of structural and functional similarities in the
calmodulin superfamily [58]. If so, observed effects of TSH on Ca2+
signaling could be due to a titration of CaBPs.
Ekokosi et al. [47] showed that cFos oncogene expression is
induced by ATP in a Ca2+-dependent manner via the P2Y-PKC cascade
and that suppression of Ca2+ signaling using chelating agents like
BAPTA abolishes cFos induction. Overexpression of a CaBP like S100A4
and the subsequent attenuation of intracellular Ca2+ signals lead to a
reduced stimulation of cFos expression, demonstrating how CaBP
expression could affect central signaling pathways.
Taken together we present strong evidence that TSH has the ability
to tune Ca2+ signals elicited by other receptors through the regulation
of CaBP expression. This represents a novel putative cross-regulating
mechanism in thyrocytes that could affect the feedback loop to TSH/
cAMP signaling via activated calmodulin-dependent phosphodiester-
ase, or inﬂuence thyroid physiology in terms of H2O2 production.
Furthermore, we demonstrate that the metastasis-associated protein
S100A4 interacts with purinergic signaling in follicular thyroid cancer
cells. The impact of this interaction on cancer biology remains an
interesting subject for further studies.Acknowledgements
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